By Amy Norton
WEDNESDAY, July one, 2020 (HealthDay News)
Scientists are reporting an early stage toward an HIV drug that could possibly be taken only a few of times for each 12 months.
A solitary injection of the experimental drug, referred to as lenacapavir, was capable to reduce blood levels of HIV in a compact group of clients. And it was capable of preserving lively levels in the blood for far more than 6 months.
It all raises the likelihood of 1 working day having an HIV remedy that only desires to be taken 2 times a 12